125 related articles for article (PubMed ID: 19082437)
1. Knockdown of Dicer in MCF-7 human breast carcinoma cells results in G1 arrest and increased sensitivity to cisplatin.
Bu Y; Lu C; Bian C; Wang J; Li J; Zhang B; Li Z; Brewer G; Zhao RC
Oncol Rep; 2009 Jan; 21(1):13-7. PubMed ID: 19082437
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Dicer increases sensitivity to gefitinib in human lung cancer cells.
Chen JC; Su YH; Chiu CF; Chang YW; Yu YH; Tseng CF; Chen HA; Su JL
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S555-63. PubMed ID: 24723223
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel.
Wang C; Pan YH; Shan M; Xu M; Bao JL; Zhao LM
Int J Mol Sci; 2015 Mar; 16(3):4698-712. PubMed ID: 25739083
[TBL] [Abstract][Full Text] [Related]
4. Dicer affects cisplatin‑mediated apoptosis in epithelial ovarian cancer cells.
Wang X; Chen H; Wen Y; Yang X; Han Q; Jiang P; Huang Z; Cai J; Wang Z
Mol Med Rep; 2018 Nov; 18(5):4381-4387. PubMed ID: 30221734
[TBL] [Abstract][Full Text] [Related]
5. Dicer, Drosha, and outcomes in patients with ovarian cancer.
Merritt WM; Lin YG; Han LY; Kamat AA; Spannuth WA; Schmandt R; Urbauer D; Pennacchio LA; Cheng JF; Nick AM; Deavers MT; Mourad-Zeidan A; Wang H; Mueller P; Lenburg ME; Gray JW; Mok S; Birrer MJ; Lopez-Berestein G; Coleman RL; Bar-Eli M; Sood AK
N Engl J Med; 2008 Dec; 359(25):2641-50. PubMed ID: 19092150
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
7. AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.
Shi Z; Zhang J; Qian X; Han L; Zhang K; Chen L; Liu J; Ren Y; Yang M; Zhang A; Pu P; Kang C
Cancer Res; 2013 Sep; 73(17):5519-31. PubMed ID: 23811941
[TBL] [Abstract][Full Text] [Related]
8. PRPS1 silencing reverses cisplatin resistance in human breast cancer cells.
He M; Chao L; You YP
Biochem Cell Biol; 2017 Jun; 95(3):385-393. PubMed ID: 28177767
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
10. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Med19 suppresses proliferation and enhances chemo-sensitivity to cisplatin in non-small cell lung cancer cells.
Wei L; Wang XW; Sun JJ; Lv LY; Xie L; Song XR
Asian Pac J Cancer Prev; 2015; 16(3):875-80. PubMed ID: 25735376
[TBL] [Abstract][Full Text] [Related]
12. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells.
Zhou W; Wang J; Man WY; Zhang QW; Xu WG
Asian Pac J Cancer Prev; 2015; 16(6):2425-30. PubMed ID: 25824776
[TBL] [Abstract][Full Text] [Related]
13. Silencing CDR1as enhances the sensitivity of breast cancer cells to drug resistance by acting as a miR-7 sponge to down-regulate REGγ.
Yang W; Yang X; Wang X; Gu J; Zhou D; Wang Y; Yin B; Guo J; Zhou M
J Cell Mol Med; 2019 Aug; 23(8):4921-4932. PubMed ID: 31245927
[TBL] [Abstract][Full Text] [Related]
14. MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer.
He H; Tian W; Chen H; Jiang K
Tumour Biol; 2016 Feb; 37(2):1599-607. PubMed ID: 26298722
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
Wan J; Shi F; Xu Z; Zhao M
Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype.
Grelier G; Voirin N; Ay AS; Cox DG; Chabaud S; Treilleux I; Léon-Goddard S; Rimokh R; Mikaelian I; Venoux C; Puisieux A; Lasset C; Moyret-Lalle C
Br J Cancer; 2009 Aug; 101(4):673-83. PubMed ID: 19672267
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
19. Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.
Pogribny IP; Filkowski JN; Tryndyak VP; Golubov A; Shpyleva SI; Kovalchuk O
Int J Cancer; 2010 Oct; 127(8):1785-94. PubMed ID: 20099276
[TBL] [Abstract][Full Text] [Related]
20. DICER-dependent biogenesis of let-7 miRNAs affects human cell response to DNA damage via targeting p21/p27.
Liu B; Liu M; Wang J; Zhang X; Wang X; Wang P; Wang H; Li W; Wang Y
Nucleic Acids Res; 2015 Feb; 43(3):1626-36. PubMed ID: 25578966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
